1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges,
Trends
4. Voice of Customer
5. Global Behavioural
Rehabilitation Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Behavioural
Disorder (Anxiety Disorder, Mood Disorder, Substance Abuse Disorder,
Personality Disorder, and Attention Deficit Disorder)
5.2.2. By Healthcare Setting
(Outpatient Behavioural Rehabilitation, Inpatient Behavioural Rehabilitation,
and Residential Behavioural Rehabilitation)
5.2.3. By Treatment Method
(Counselling, Medication, Support Services, and Other Treatment Methods)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Behavioural
Rehabilitation Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Behavioural
Disorder
6.2.2. By Healthcare Setting
6.2.3. By Treatment Method
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Behavioural
Rehabilitation Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By
Type of Behavioural Disorder
6.3.1.2.2. By
Healthcare Setting
6.3.1.2.3. By
Treatment Method
6.3.2. Canada Behavioural
Rehabilitation Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By
Type of Behavioural Disorder
6.3.2.2.2. By
Healthcare Setting
6.3.2.2.3. By
Treatment Method
6.3.3. Mexico Behavioural
Rehabilitation Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By
Type of Behavioural Disorder
6.3.3.2.2. By
Healthcare Setting
6.3.3.2.3. By
Treatment Method
7. Europe Behavioural
Rehabilitation Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Behavioural
Disorder
7.2.2. By Healthcare Setting
7.2.3. By Treatment Method
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Behavioural
Rehabilitation Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By
Type of Behavioural Disorder
7.3.1.2.2. By
Healthcare Setting
7.3.1.2.3. By
Treatment Method
7.3.2. United Kingdom Behavioural
Rehabilitation Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By
Type of Behavioural Disorder
7.3.2.2.2. By
Healthcare Setting
7.3.2.2.3. By
Treatment Method
7.3.3. Italy Behavioural
Rehabilitation Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By
Type of Behavioural Disorder
7.3.3.2.2. By
Healthcare Setting
7.3.3.2.3. By
Treatment Method
7.3.4. France Behavioural
Rehabilitation Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By
Type of Behavioural Disorder
7.3.4.2.2. By
Healthcare Setting
7.3.4.2.3. By
Treatment Method
7.3.5. Spain Behavioural
Rehabilitation Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By
Type of Behavioural Disorder
7.3.5.2.2. By
Healthcare Setting
7.3.5.2.3. By
Treatment Method
8. Asia-Pacific Behavioural
Rehabilitation Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Behavioural
Disorder
8.2.2. By Healthcare Setting
8.2.3. By Treatment Method
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Behavioural
Rehabilitation Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By
Type of Behavioural Disorder
8.3.1.2.2. By
Healthcare Setting
8.3.1.2.3. By
Treatment Method
8.3.2. India Behavioural
Rehabilitation Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By
Type of Behavioural Disorder
8.3.2.2.2. By
Healthcare Setting
8.3.2.2.3. By
Treatment Method
8.3.3. Japan Behavioural
Rehabilitation Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By
Type of Behavioural Disorder
8.3.3.2.2. By
Healthcare Setting
8.3.3.2.3. By
Treatment Method
8.3.4. South Korea Behavioural
Rehabilitation Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By
Type of Behavioural Disorder
8.3.4.2.2. By
Healthcare Setting
8.3.4.2.3. By
Treatment Method
8.3.5. Australia Behavioural
Rehabilitation Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By
Type of Behavioural Disorder
8.3.5.2.2. By
Healthcare Setting
8.3.5.2.3. By
Treatment Method
9. South America Behavioural
Rehabilitation Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Behavioural
Disorder
9.2.2. By Healthcare Setting
9.2.3. By Treatment Method
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Behavioural
Rehabilitation Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By
Type of Behavioural Disorder
9.3.1.2.2. By
Healthcare Setting
9.3.1.2.3. By
Treatment Method
9.3.2. Argentina Behavioural
Rehabilitation Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By
Type of Behavioural Disorder
9.3.2.2.2. By
Healthcare Setting
9.3.2.2.3. By
Treatment Method
9.3.3. Colombia Behavioural
Rehabilitation Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By
Type of Behavioural Disorder
9.3.3.2.2. By
Healthcare Setting
9.3.3.2.3. By
Treatment Method
10. Middle East and Africa Behavioural
Rehabilitation Market Outlook
10.1. Market
Size & Forecast
10.1.1. By Value
10.2. Market
Share & Forecast
10.2.1. By Type of Behavioural Disorder
10.2.2. By Healthcare Setting
10.2.3. By Treatment Method
10.2.4. By Country
10.3. MEA:
Country Analysis
10.3.1. South Africa Behavioural
Rehabilitation Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By
Type of Behavioural Disorder
10.3.1.2.2. By
Healthcare Setting
10.3.1.2.3. By
Treatment Method
10.3.2. Saudi Arabia Behavioural
Rehabilitation Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By
Type of Behavioural Disorder
10.3.2.2.2. By
Healthcare Setting
10.3.2.2.3. By
Treatment Method
10.3.3. UAE Behavioural Rehabilitation Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By
Type of Behavioural Disorder
10.3.3.2.2. By
Healthcare Setting
10.3.3.2.3. By
Treatment Method
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger
& Acquisition (If Any)
12.2. Product
Launches (If Any)
12.3. Recent
Developments
13. Porter’s Five Forces Analysis
13.1. Competition
in the Industry
13.2. Potential
of New Entrants
13.3. Power
of Suppliers
13.4. Power
of Customers
13.5. Threat
of Substitute Products
14. Competitive Landscape
14.1. Allergan,
Inc.
14.1.1. Business
Overview
14.1.2. Company
Snapshot
14.1.3. Products
& Services
14.1.4. Financials
(As Reported)
14.1.5. Recent
Developments
14.1.6. Key
Personnel Details
14.1.7. SWOT
Analysis
14.2. Novartis AG
14.3. Taro Pharmaceutical Industries
14.4. Perrigo Company plc
14.5. Zynerba Pharmaceuticals
14.6. Apotex Inc.
14.7. Sandoz AG
14.8. Strides Arcolab Ltd.
14.9. TOLMAR Pharmaceuticals, Inc.
14.10. Limbix Health Inc.
15. Strategic Recommendations
16. About Us & Disclaimer